Structural biology in Drug Discovery

Structural biology, the study of the structure of biological macromolecules, is suitable a physical advantage in the drug development process. Structural biology seeks to provide a complete and coherent picture of biological phenomena at the molecular and atomic level. The aims of structural biology consist of inconstant a complete understanding of the molecular shapes and forms embraced by biological macromolecules and extending this knowledge to understand how different molecular architectures are used to perform the chemical reactions that are central to life.

  • 3D structures of proteins
  • Computational Biology
  • NMR spectroscopy
  • Recent Development in Genomes
  • X-ray crystallography
  • Lead optimization
  • Target Proteins
  • Identifying ligand binding regions
  • Target Identification

Related Conference of Structural biology in Drug Discovery

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

Structural biology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in